TI
IMNM icon

Trexquant Investment’s Immunome IMNM Stock Holding History

Trexquant Investment’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Sell
88,391
-78,421
-47% -$1.68M 0.01% 1223
2026
Q1 		$3.65M Buy
166,812
+35,978
+27% +$801K 0.03% 780
2025
Q4 		$2.81M Buy
+130,834
New +$2.3M 0.03% 851

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Trexquant Investment's IMNM Position: Q2 2026 in Review

Trexquant Investment reduced its Immunome (IMNM) stake by 47% in Q2 2026, selling an estimated $1.68M and leaving 88,391 shares worth $1.87M. The position accounts for 0.01% of the portfolio, ranked #1223.

Trexquant Investment first reported a position in IMNM in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.65M in Q1 2026. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Trexquant Investment held 88,391 shares of Immunome worth $1.87M as of Q2 2026.
  • Trexquant Investment sold 78,421 Immunome shares in Q2 2026, an estimated $1.68M.
  • Immunome made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1223 holding.
  • Trexquant Investment first reported a position in Immunome in Q4 2025 and has held it in 3 quarters since.
  • Trexquant Investment's Immunome position peaked at $3.65M in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.